XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021     195,384        
Beginning balance at Dec. 31, 2021 $ 985,648   $ 2 $ 1,500,643 $ (513,230)   $ (1,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 6,135     6,135      
Stock option exercises (in shares)     126        
Stock option exercises 723     723      
Foreign currency translation losses, net (664)           (664)
Net loss (13,309)       (13,309)    
Ending balance (in shares) at Mar. 31, 2022     195,510        
Ending balance at Mar. 31, 2022 978,533   $ 2 1,507,501 (526,539)   (2,431)
Beginning balance (in shares) at Dec. 31, 2021     195,384        
Beginning balance at Dec. 31, 2021 985,648   $ 2 1,500,643 (513,230)   (1,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation losses, net (15,811)            
Net loss (42,043)            
Ending balance (in shares) at Sep. 30, 2022     193,938        
Ending balance at Sep. 30, 2022 929,136   $ 2 1,501,985 (555,273)   (17,578)
Beginning balance (in shares) at Dec. 31, 2021     195,384        
Beginning balance at Dec. 31, 2021 985,648   $ 2 1,500,643 (513,230)   (1,767)
Ending balance (in shares) at Dec. 31, 2022     191,447        
Ending balance at Dec. 31, 2022 $ 906,693 $ (1,309) $ 2 1,489,935 (573,046) $ (1,309) (10,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]            
Beginning balance (in shares) at Mar. 31, 2022     195,510        
Beginning balance at Mar. 31, 2022 $ 978,533   $ 2 1,507,501 (526,539)   (2,431)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (in shares)     218        
Issuance of common stock for Employee Stock Purchase Plan 1,804     1,804      
Stock-based compensation 6,508     6,508      
Stock option exercises (in shares)     96        
Stock option exercises 381     381      
Repurchase and retirement of common stock including taxes (in shares)     (296)        
Repurchase and retirement of common stock including taxes (2,665)     (2,665)      
Foreign currency translation losses, net (8,169)           (8,169)
Net loss (12,881)       (12,881)    
Ending balance (in shares) at Jun. 30, 2022     195,528        
Ending balance at Jun. 30, 2022 963,511   $ 2 1,513,529 (539,420)   (10,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (50)            
Common stock issued upon vesting of restricted stock units (in shares)     116        
Stock-based compensation 7,133     7,133      
Stock option exercises (in shares)     95        
Stock option exercises 571     571      
Repurchase and retirement of common stock including taxes (in shares)     (1,801)        
Repurchase and retirement of common stock including taxes (19,198)            
Foreign currency translation losses, net (6,978)           (6,978)
Net loss (15,853)       (15,853)    
Ending balance (in shares) at Sep. 30, 2022     193,938        
Ending balance at Sep. 30, 2022 929,136   $ 2 1,501,985 (555,273)   (17,578)
Beginning balance (in shares) at Dec. 31, 2022     191,447        
Beginning balance at Dec. 31, 2022 906,693 (1,309) $ 2 1,489,935 (573,046) (1,309) (10,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued upon vesting of restricted stock units (in shares)     348        
Stock-based compensation $ 7,514     7,514      
Stock option exercises (in shares) 103   103        
Stock option exercises $ 609     609      
Repurchase and retirement of common stock including taxes (in shares)     (3,124)        
Repurchase and retirement of common stock including taxes (29,643)     (29,643)      
Foreign currency translation losses, net (99)           (99)
Net loss (20,775)       (20,775)    
Ending balance (in shares) at Mar. 31, 2023     188,774        
Ending balance at Mar. 31, 2023 862,990   $ 2 1,468,415 (595,130)   (10,297)
Beginning balance (in shares) at Dec. 31, 2022     191,447        
Beginning balance at Dec. 31, 2022 $ 906,693 $ (1,309) $ 2 1,489,935 (573,046) $ (1,309) (10,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase and retirement of common stock including taxes (in shares) (4,200)            
Foreign currency translation losses, net $ (2,721)            
Net loss (22,285)            
Ending balance (in shares) at Sep. 30, 2023     188,927        
Ending balance at Sep. 30, 2023 862,156   $ 2 1,471,713 (596,640)   (12,919)
Beginning balance (in shares) at Mar. 31, 2023     188,774        
Beginning balance at Mar. 31, 2023 862,990   $ 2 1,468,415 (595,130)   (10,297)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (in shares)     324        
Issuance of common stock for Employee Stock Purchase Plan 1,765     1,765      
Common stock issued upon vesting of restricted stock units (in shares)     404        
Stock-based compensation $ 6,241     6,241      
Stock option exercises (in shares) 38   38        
Stock option exercises $ 300     300      
Repurchase and retirement of common stock including taxes (in shares)     (904)        
Repurchase and retirement of common stock including taxes (10,361)     (10,361)      
Foreign currency translation losses, net (682)           (682)
Net loss (896)       (896)    
Ending balance (in shares) at Jun. 30, 2023     188,636        
Ending balance at Jun. 30, 2023 859,357   $ 2 1,466,360 (596,026)   (10,979)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued upon vesting of restricted stock units (in shares)     295        
Stock-based compensation $ 5,855     5,855      
Stock option exercises (in shares) 156   156        
Stock option exercises $ 1,073     1,073      
Repurchase and retirement of common stock including taxes (in shares) (200)   (160)        
Repurchase and retirement of common stock including taxes $ (1,575)     (1,575)      
Foreign currency translation losses, net (1,940)           (1,940)
Net loss (614)       (614)    
Ending balance (in shares) at Sep. 30, 2023     188,927        
Ending balance at Sep. 30, 2023 $ 862,156   $ 2 $ 1,471,713 $ (596,640)   $ (12,919)